Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellectis (CLLS) Shares Outstanding (Diluted Average) (2021 - 2025)

Cellectis has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $100.3 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $100.3 million for Q4 2025, up 10.72% from a year ago — trailing twelve months through Dec 2025 was $100.3 million (up 10.72% YoY), and the annual figure for FY2025 was $100.3 million, up 10.72%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $100.3 million at Cellectis, up from $90.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CLLS hit a ceiling of $100.3 million in Q4 2025 and a floor of $44.8 million in Q4 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $57.0 million (2023), compared with a mean of $67.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 1.62% in 2022 and later soared 58.85% in 2024.
  • Cellectis' Shares Outstanding (Diluted Average) stood at $44.8 million in 2021, then rose by 1.62% to $45.5 million in 2022, then rose by 25.17% to $57.0 million in 2023, then soared by 58.85% to $90.6 million in 2024, then increased by 10.72% to $100.3 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $100.3 million (Q4 2025), $90.6 million (Q4 2024), and $57.0 million (Q4 2023) per Business Quant data.